What is the appropriate management of hyponatremia in a patient with sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Hyponatremia in Sepsis

In septic patients with hyponatremia, use isotonic crystalloids (0.9% saline or balanced crystalloids) for resuscitation and avoid hypotonic fluids entirely, as sepsis drives intracellular sodium and water shifts that are exacerbated by dextrose-containing solutions; reserve hypertonic saline (3% NaCl) only for severely symptomatic hyponatremia with neurologic manifestations. 1, 2

Fluid Selection in Septic Hyponatremia

First-Line Crystalloid Choice

  • Isotonic crystalloids (0.9% saline or balanced crystalloids) are mandatory for initial resuscitation and all subsequent volume replacement in septic patients with hyponatremia 1.
  • Balanced crystalloids may be preferred over normal saline because they carry lower risk of renal dysfunction, though both are acceptable 1.
  • Dextrose-containing solutions (5% dextrose or 0.18% saline/4% dextrose) are contraindicated in septic hyponatremia because they worsen intracellular water accumulation and plasma hypoosmolality 2.

Pathophysiology Driving Fluid Choice

  • Sepsis causes significant intracellular shifts of sodium, chloride, and water into muscle cells even before exogenous fluid administration 2.
  • This intracellular shift is dramatically exacerbated by hypotonic fluid administration, leading to reduced extracellular volume, worsened hyponatremia, and plasma hypoosmolality 2.
  • The mechanism involves physiologic ADH secretion in sepsis combined with dilution of extracellular space when hypotonic fluids are given 2.

Restrictive Fluid Strategy Framework

Initial Resuscitation (First Hour)

  • Administer 500–1000 mL crystalloid bolus and reassess hemodynamics within 10–60 minutes 1.
  • Start norepinephrine immediately if MAP remains <65 mmHg after the initial bolus rather than giving additional large-volume fluids 1.
  • Target MAP ≥65 mmHg with early vasopressor integration 1.

Ongoing Fluid Assessment

  • Evaluate fluid responsiveness before every additional bolus using dynamic tests: passive leg raise, pulse pressure variation ≥13% (if mechanically ventilated with tidal volume ≥8 mL/kg), or stroke volume variation 1.
  • Give additional fluid only to fluid-responsive patients; administering fluids to non-responders causes hemodilution, reduced oxygen delivery, pulmonary edema, and acute kidney injury 1.
  • Reassess fluid responsiveness repeatedly because only 50% of initial responders maintain positive response after 30 minutes 1.

Maintenance Phase

  • When MAP ≥65 mmHg and no ongoing hypovolemia, transition to maintenance crystalloid infusion of 1.0–1.5 mL/kg/h (approximately 75–100 mL/h for 70-kg adult) 1.
  • Avoid static measures (central venous pressure, IVC diameter) to guide fluid therapy as they poorly predict fluid responsiveness 1.

Hypertonic Saline: Reserved for Severe Symptoms Only

Indications for 3% Saline

  • Severely symptomatic hyponatremia with somnolence, obtundation, coma, seizures, or cardiorespiratory distress is a medical emergency requiring hypertonic saline 3, 4.
  • Administer 100–150 mL bolus of 3% NaCl to increase serum sodium by 4–6 mEq/L within 1–2 hours 5, 4.

Correction Limits to Prevent Osmotic Demyelination

  • Maximum correction: 6–8 mEq/L in 24 hours, 12–14 mEq/L in 48 hours, 14–16 mEq/L in 72 hours 4.
  • Never exceed 10 mEq/L in 24 hours to avoid osmotic demyelination syndrome 4.
  • Monitor serum sodium every 2–4 hours during active correction 5, 4.
  • Have desmopressin available to terminate unwanted water diuresis if overcorrection occurs 4, 6.

Asymptomatic or Mildly Symptomatic Hyponatremia

  • Do not use hypertonic saline in asymptomatic septic hyponatremia 5, 3.
  • Focus on adequate solute intake (salt and protein) and treating the underlying sepsis 5.
  • Fluid restriction (500 mL/day initially) may be considered in euvolemic SIADH-mediated hyponatremia, but nearly half of SIADH patients do not respond to fluid restriction alone 5.

Prognostic Considerations

Mortality Predictors

  • Sepsis with hyponatremia carries 20% mortality, with hypoxia, neurologic symptoms, and sepsis itself being independent predictors of death 7.
  • Slow correction rates in severe hyponatremia are associated with higher mortality than appropriately rapid correction in symptomatic patients 7.
  • More aggressive therapy with 3% saline may improve outcomes only in symptomatic patients 7.

Critical Pitfalls to Avoid

  • Never use dextrose-containing solutions for resuscitation or maintenance in septic patients with hyponatremia 2.
  • Do not give additional fluid boluses without confirming fluid responsiveness after initial resuscitation 1.
  • Avoid fluid overload, which contributes to pulmonary edema, renal dysfunction, and increased intra-abdominal pressure 1.
  • Do not use hypertonic saline for asymptomatic hyponatremia in sepsis; the primary treatment is isotonic crystalloid resuscitation and treating the infection 1, 5.

References

Guideline

Restrictive Fluid Therapy in Septic Shock – Evidence Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The treatment of hyponatremia.

Seminars in nephrology, 2009

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

Predictors of outcome in hospitalized patients with severe hyponatremia.

Journal of the National Medical Association, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.